Two papers show how AAV packages its DNA and how influenza damages the heart.
There is no multi-organ viremia. A specialized myeloid cell, the CD319-positive pro-DC3, is infected in the lung and ferries virus through the circulation to the heart, where it passes the virus to heart muscle cells, the cardiomyocytes. Parabiosis experiments ruled out simple spread from the neighbouring lung.
Answered around 46:00Not the virus itself. Cardiac titres peak and fall before symptoms appear; the damage comes from type 1 interferon signalling on cardiomyocytes. Mice lacking the type 1 interferon receptor, IFNAR, were protected, with reduced troponin and better left ventricular ejection fraction, and poly-IC alone released troponin.
Answered around 1:15:58Probably not, because the virus is largely cleared from the heart before cardiac symptoms appear; in mice titres drop after day six. An antiviral given at symptom onset arrives too late, since the damage is driven by the interferon response that follows, so timing of therapy matters.
Answered around 46:39Yes. In the mouse model vaccination protected the heart, which the hosts call another reason to get vaccinated. The authors do not test it extensively, but they state that protection can still occur when the vaccine is mismatched to the infecting virus. It was a supplemental figure.
Answered around 53:06Only cardiomyocytes. Using the viral NS1 protein as an infection marker, the authors found it in heart muscle cells but not in endothelial cells or fibroblasts. Those infected cardiomyocytes die after replication, and adult mammals regenerate only about one percent of them, so loss is largely permanent.
Answered around 1:11:32Across nineteen tissues, the heart and aorta are the richest in the chemokine CCL2 at homeostasis, and levels rise further after infection. The infected LY6C-high pro-DC3s carry its receptor CCR2, so they are recruited there. Transferred cells lacking CCR2 produced no cardiac phenotype, and blocking CCL2 lowered cardiac viral loads.
Answered around 1:06:47A pentamer of five Rep40 molecules docks on a five-fold vertex of the empty capsid as a platform. A heptamer bound to the DNA's inverted terminal repeat lands on it, then donates one subunit, leaving two hexamers; that subunit loss melts the duplex so single-stranded DNA threads in.
Answered around 17:56Rep has four isoforms, Rep78, 68, 52 and 40, named for molecular weights, and all have helicase activity, a motor protein that separates double-stranded nucleic acids using energy from ATP hydrolysis. Rep78 and 68 nick and unwind DNA during replication; Rep52 and Rep40 package DNA into empty capsids.
Answered around 15:18Seven AAV-based gene therapy products already have FDA or EMA approval, including one injected into the retina that resolves some kinds of blindness, and there are about 230 clinical trials worldwide. AAVs are easy to manipulate and give long-term expression because they stay episomal rather than integrating.
Answered around 22:07A federal judge in Massachusetts blocked the government on Monday from implementing a series of vaccine decisions made over the past year by health secretary RFK Jr. The ruling reversed, at least for now, decisions by his appointees to the Advisory Committee on Immunization Practices and stopped its scheduled meeting.
Answered around 7:40“And if it were me, I would go to the American Academy of Pediatrics.”
“They just did a nice job of comparison to other viruses and what's known about helicases.”
“And then, which I think is really important, vaccination protected the heart.”
“That also doesn't seem like a great thing evolution-wise for these nice precious cells.”
“ASV 2026 Meeting Updates.” https://traffic.libsyn.com/secure/twiv/TWiV1307.mp3. Transcript summary by WhipScribe, https://whipscribe.com/transcript-pages/asv-2026-meeting-updates.html.